New rules on medical marijuana research could play into Pennsylvania legislative process


pennsylvaniammj

Last week the U.S. Drug Enforcement Administration relaxed regulations on medical marijuana research, with potential implications for approval of laws in Pennsylvania.

Loosening regulations on medical marijuana research should streamline the process for researchers conducting FDA-approved clinical trials on cannabidiol, or CBD, an extract of the marijuana plant, according to a news release from the DEA.

Source:  New rules on medical marijuana research could play into Pennsylvania legislative process | Central Penn Business Journal

Leave a comment

Your email address will not be published. Required fields are marked *